Trial Profile
A Phase IIb/III trial of TG01 for Resected Pancreas
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 08 Nov 2017
Price :
$35
*
At a glance
- Drugs TG 01 Targovax (Primary)
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors Targovax
- 08 Nov 2017 New trial record